ReviewHuman reproduction open2024

No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.

Alexander Katalinic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.